Below is a list of Kidney Stones clinical trials from the clinical trials database at Mayo Clinic.
Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.
Oxazyme in Hyperoxaluria Patients With Kidney Stones
This research study investigates whether taking a new medical food product called Oxazyme can break down oxalate from foods you have eaten and prevent too much oxalate from reaching the kidneys. This study is open to patients who have hyperoxaluria and have had a history of calcium oxalate kidney stones within the last five years.
Read more
Registry database to collect medical information on Dent Disease Patients
The Dent disease Registry will help physicians, patients and their families better understand Dent patients. The Registry is a web-based, confidential database.The information about your health will be maintained in the registry only by your assigned number and not by your name.
Read more
SLC26 and idiopathic calcium oxalate urolithiasis (kidney stones)
Idiopathic calcium oxalate urolithiasis affects 12% of men and 5% of women in the industrialized world. Familial aggregation patterns, and more recently, twin studies, have suggested a strong genetic basis. Recently, there has been an increasing appreciation of a family of anion transporters (Solute-Linked Carrier Family 26 or SLC26) with a capacity to transport oxalate.
Read more
Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery
Large kidney stones can be removed by a surgical procedure where a small puncture is made through the back into the kidney (percutaneous nephrolithotomy or PNL) but the stones usually need to be broken into smaller pieces before they can be removed through the small surgical incision.
Read more
Use of Symbiotics to Reduce Urinary Oxalate Excretion
Renal manifestations of chronic hyperoxaluria include nephrolithiasis and, when extreme, interstitial scarring and progressive loss of function. The clinical outcome can be dismal. Although primary hyperoxaluria is relatively rare, hyperoxaluria secondary to gastrointestinal malabsorption is not.
Read more
Find Mayo Clinic on